Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Migraine and mitochondrial dysfunction]

M Lantéri-Minet1, C Desnuelle

  • 1Service de Neurologie, (Pr Chatel), CHU de Nice.

Revue Neurologique
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study.

Revue neurologique·2026
Same author

Trends in the real-world management of cluster headache patients treated by subcutaneous sumatriptan and/or oxygen in France - An analysis of the French National Social Security System Open Data over eleven years (2014-2024).

Revue neurologique·2025
Same author

Cluster headache suicidality: a systematic review with a meta-analysis.

The journal of headache and pain·2025
Same author

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

European journal of neurology·2025
Same author

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study.

The journal of headache and pain·2025
Same author

Cluster headache diagnostic delay and its predictors: a systematic review with a meta-analysis.

The journal of headache and pain·2025
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Mitochondrial dysfunction may contribute to migraine neurological disease. This review explores evidence supporting the mitochondrial hypothesis of migraine, including clinical and biochemical data.

Area of Science:

  • Neurology
  • Mitochondrial Biology
  • Metabolic Disorders

Context:

  • Migraine is a complex neurological disorder with significant unmet therapeutic needs.
  • Growing evidence suggests a role for cellular energy metabolism dysfunction in migraine pathophysiology.
  • Mitochondrial abnormalities, specifically in cerebral oxidative metabolism, are increasingly implicated.

Purpose:

  • To review and synthesize current clinical, biochemical, and imaging data relevant to the mitochondrial hypothesis of migraine.
  • To evaluate the evidence supporting the role of mitochondrial dysfunction in migraine.
  • To discuss potential therapeutic strategies targeting mitochondrial pathways.

Summary:

  • This review consolidates findings from clinical observations, in vivo magnetic resonance spectroscopy (MRS) studies, and biochemical assays.

Related Experiment Videos

  • Evidence indicates abnormalities in cerebral oxidative metabolism, linked to mitochondrial function, may be a key factor in migraine.
  • Therapeutic outcomes are examined in the context of mitochondrial involvement.

    • Impact:

    • Provides a comprehensive overview of the mitochondrial hypothesis of migraine for researchers and clinicians.
    • Highlights the potential of targeting mitochondrial dysfunction for novel migraine treatments.
    • Suggests a paradigm shift in understanding migraine etiology towards cellular metabolic processes.